The long-term follow up results of Kay-Shiley heart valve prostheses

A Y Bozer1, I I Günay, G Ipek

  • 1Department of Thoracic and Cardiovascular Surgery, Medical Faculty of Hacettepe University, Ankara, Turkey.

Insights

This study evaluated Kay-Shiley disc valve performance in 323 patients, revealing significant early mortality and long-term survival challenges. Thromboembolism and valve failure were key concerns in this early cardiac valve replacement series.

Area of Science:

  • Cardiovascular Surgery
  • Biomedical Engineering
  • Clinical Outcomes Research

Background:

  • The Kay-Shiley disc valve was an early prosthetic device used for heart valve replacement.
  • Understanding the long-term performance and complications of these early valves is crucial for historical context and future device development.

Purpose of the Study:

  • To assess the early and late outcomes of Kay-Shiley disc valve implantation.
  • To evaluate survival rates, thromboembolic events, and valve failure in patients undergoing valve replacement.

Main Methods:

  • A retrospective analysis of 323 patients who received 336 Kay-Shiley disc valve implants between 1968 and 1975.
  • Follow-up ranged from 1 to 16 years, with evaluation of mortality, morbidity, and valve-related complications.

Main Results:

  • Early mortality was 16.5% (52 deaths) in the early postoperative period.
  • Actuarial survival estimates at 1, 5, and 10 years were 88%, 60.3%, and 36.3%, respectively.
  • The incidence of thromboemboli was 4.2% per patient-year, and valve failure due to thrombosis occurred in 3% of cases.

Conclusions:

  • The Kay-Shiley disc valve demonstrated significant early mortality and limited long-term survival in this patient cohort.
  • Thromboembolic complications and valve thrombosis were notable issues, impacting patient outcomes.
  • These findings highlight the challenges associated with early prosthetic valve technology.

Related Concept Videos

Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...